GSK reveals gift of 50m swine flu jabs to developing world

Relax News
Monday 09 November 2009 20:00 EST
Comments
(AFP/THIERRY ZOCCOLAN)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

British pharmaceutical giant GlaxoSmithKline (GSK) said on Tuesday it will donate 50 million doses of its swine flu vaccine to the World Health Organisation (WHO) to distribute to developing countries.

The drugs company is working with the WHO and health authorities to deliver initial shipments of the H1N1 vaccine by the end of November, it said in a statement.

"GSK is committed to supporting governments and health authorities around the world in their efforts to protect their populations against this pandemic," said GSK chief executive Andrew Witty said.

WHO director general Margaret Chan welcomed the "very generous donation".

"This is a real gesture of global solidarity towards those who would not otherwise be able to have access to the vaccine. WHO will now work to see that these vaccines are distributed to those who need them," she said.

GSK has also agreed to sell the vaccine to developing countries at a reduced price, the drugs company said, and is in talks with the WHO about a donation of its antiviral medicine, Relenza.

More than 5,700 people have died worldwide since the A(H1N1) virus was first discovered in April, most of them in the Americas region, according to the WHO.

ar/mt/hd

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in